オプティマイズRxのニュース一覧

JMP SecuritiesはオプティマイズRx(OPRX.US)のレーティングを強気に据え置き、目標株価を16ドルに据え置いた

Futuニュース09/11 02:31

Lake StreetはオプティマイズRx(OPRX.US)のレーティングを強気に据え置き、目標株価を15ドルに据え置いた

Futuニュース09/10 21:32

RBC Capital Maintains Outperform on OptimizeRx, Lowers Price Target to $14

Benzinga08/16 23:27

OptimizeRx Analyst Ratings

Benzinga08/16 23:25

RBCキャピタル・マーケッツはオプティマイズRx(OPRX.US)のレーティングを強気に据え置き、目標株価を14ドルに引き下げた

Futuニュース08/16 19:34

OptimizeRx Price Target Cut to $11.00/Share From $15.00 by Barclays

Dow Jones08/12 20:35

OptimizeRx Analyst Ratings

Benzinga08/12 20:25

Lake StreetはオプティマイズRx(OPRX.US)のレーティングを強気に据え置き、目標株価を17ドルに据え置いた

Futuニュース08/06 21:33

JMP Securities Reiterates Market Outperform on OptimizeRx, Maintains $16 Price Target

Benzinga06/24 23:42

Critical Insights From OptimizeRx Analyst Ratings: What You Need To Know

Benzinga06/22 00:04

JMP Securities Reiterates Market Outperform on OptimizeRx, Maintains $16 Price Target

Benzinga06/21 23:04

OptimizeRx Analyst Ratings

Benzinga06/21 23:03

OptimizeRx Analyst Ratings

Benzinga05/15 19:55

OptimizeRx Analyst Ratings

Benzinga04/16 23:20

JMP Securities Reiterates Market Outperform on OptimizeRx, Maintains $15 Price Target

Benzinga04/16 23:20

OptimizeRx Analyst Ratings

Benzinga04/04 17:05

JMP Securities Initiates Coverage On OptimizeRx With Market Outperform Rating, Announces Price Target of $15

Benzinga04/04 17:05

OptimizeRx Analyst Ratings

Benzinga04/01 21:55

RBC Capital Reiterates Outperform on OptimizeRx, Maintains $17 Price Target

Benzinga04/01 21:55

RBC Capital Maintains Outperform on OptimizeRx, Raises Price Target to $17

Benzinga01/10 23:03